Admin Core
Admin Core
批准号:
10684938
负责人:
Marc E. Rothenberg
金额:
$60.91万
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
已结题
起止时间:
2014-08-15 至 2024-08-31
关键词:
AddressAdverse eventAdvisory CommitteesAdvocacyAmericanBiometryBudgetsClinicalClinical ResearchClinical TrialsCommunicationDataData Coordinating CenterDecision MakingDevelopmentDiseaseElementsEnrollmentEnsureEosinophilic ColitisEosinophilic EsophagitisEosinophilic GastritisEosinophilic Gastrointestinal DiseaseEthicsEventFamilyFocus GroupsFosteringFundingGoalsGuidelinesIndividualIndustryInformaticsInstitutionInternationalMonitorOnline SystemsPathologyPatientsPoliciesPositioning AttributePrincipal InvestigatorProceduresProcessProductivityProfessional OrganizationsProtocols documentationPublicationsRare DiseasesReportingResearchResearch PersonnelResearch Project GrantsRoleSiteTranslational ResearchUnited States National Institutes of Healthcareercareer developmentclinical trial readinesseosinophilic gastroenteritisinsightinterestmeetingsnewsoperationpatient advocacy grouprecruitresearch studysuccessweb site
中文摘要
项目摘要(管理核心)
这一新的应用旨在继续研究罕见的嗜酸性胃肠道疾病(EGID)
重点关注嗜酸性食管炎(EoE)、嗜酸性胃炎(EG)、嗜酸性胃肠炎(EGE)和
嗜酸性结肠炎(EC)通过嗜酸性胃肠道疾病研究联盟(CEGIR)。
CEGIR的目标是促进高度协作、多地点、以患者为中心、转化和临床研究
解决未满足的临床试验准备需求的意图。虽然仍处于相对早期的阶段,但CEGIR
通过调查人员之间的协作互动展示成功(在职业生涯的所有阶段
发展),积极主动的患者倡导团体(PAG),以及NIH的合作机构,并已
成为专注于罕见EGID的领先临床和研究小组。CEGIR管理核心
旨在有效地生成和管理与以下各项相关的政策、程序、沟通和资金
CEGIR,并确保在包括科学在内的所有层面上达到最高水平的严谨性。CEGIR
行政核心将在协调决策和执行以实现目标方面不可或缺
CEGIR的。CEGIR的行政核心将包括CEGIR主任(首席调查员)、临床试验
联络,以及CEGIR内部指导委员会。CEGIR内部指导委员会将由
在现场领导人中,PAG代表[即美国嗜酸性粒细胞疾病伙伴关系(APFED),
敦促研究嗜酸性粒细胞疾病(治愈)的运动,嗜酸性粒细胞家庭联盟(EFC)],以及
行政协调员。CEGIR行政核心的具体活动包括但不限于
以下内容:1)制定和管理研究政策;2)管理和监测预算和资金
分发;3)为CEGIR核心和委员会提供监督和指导;4)审查和分发
CEGIR核心和委员会向适当受众(例如,利益攸关方)提交的报告和会议记录;5)
根据美国国立卫生研究院(NIH)的指导方针和指令传播网络信息;6)
吸收外部咨询委员会(EAC)的宝贵见解;以及7)促进一体化和伙伴关系
与PAGS、其他罕见疾病研究联盟和利益攸关方,包括国际联络机构。这个
管理核心将管理CEGIR的运营,确保CEGIR以高效、
富有成效的、成功的举止。
英文摘要
Project Summary (Administrative Core)
This renewal application aims to continue research on rare eosinophilic gastrointestinal diseases (EGIDs) with
a focus on eosinophilic esophagitis (EoE), eosinophilic gastritis (EG), eosinophilic gastroenteritis (EGE), and
eosinophilic colitis (EC) through the Consortium of Eosinophilic Gastrointestinal Disease Researchers (CEGIR).
CEGIR aims to promote highly collaborative, multi-site, patient-centric, translational and clinical research with
the intent of addressing unmet clinical trial readiness needs. Though still in a relatively early stage, CEGIR is
demonstrating success via its collaborative interactions between investigators (at all stages of career
development), proactive patient advocacy groups (PAGs), and partnering institutions at the NIH and has
emerged into the leading clinical and research group focused on rare EGIDs. The CEGIR Administrative Core
aims to effectively generate and administer the policies, procedures, communications, and funds associated with
CEGIR and ensure that the highest level of rigor, at all levels including scientific, is achieved. The CEGIR
Administrative Core will be integral in coordinating decision-making and implementation to achieve the objectives
of CEGIR. The CEGIR Administrative Core will include the CEGIR Director (Principal Investigator), Clinical Trial
Liaison, and the CEGIR Internal Steering Committee. The CEGIR Internal Steering Committee will be composed
of the Site Leaders, PAG representatives [i.e., American Partnership for Eosinophilic Disorders (APFED),
Campaign Urging Research for Eosinophilic Diseases (CURED), Eosinophilic Family Coalition (EFC)], and
Administrative Coordinators. Specific activities of the CEGIR Administrative Core include but are not limited to
the following: 1) generate and administer research policies; 2) administer and monitor budgets and fund
distribution; 3) provide oversight and guidance for CEGIR Cores and Committees; 4) review and distribute
reports and proceedings from CEGIR Cores and Committees to appropriate audiences (e.g., stakeholders); 5)
disseminate web-based information as per National Institutes of Health (NIH) guidelines and directives; 6)
integrate valuable insight from the External Advisory Committee (EAC); and 7) foster integration and partnership
with PAGs, other Rare Diseases Research Consortia, and stakeholders, including international liaisons. The
Administrative Core will manage CEGIR operations ensuring that CEGIR achieves its goals in efficient,
productive, and successful manners.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Consortium of Eosinophilic Gastrointestinal Disease Researchers-HEROs Supplement
-
批准号:10166192
-
项目类别:
-
资助金额:$11.43万
-
财政年份:2020
-
负责人:Marc E. Rothenberg
-
依托单位:
Consortium of Eosinophilic Gastrointestinal Disease Researchers
-
批准号:10242554
-
项目类别:
-
资助金额:$13.82万
-
财政年份:2020
-
负责人:Marc E. Rothenberg
-
依托单位:
Roles of FFAR 3-SCFA axis in Th2 cytokine production by tissuelymphocytes in EoE
-
批准号:10063468
-
项目类别:
-
资助金额:$39.75万
-
财政年份:2019
-
负责人:Marc E. Rothenberg
-
依托单位:
Roles of FFAR 3-SCFA axis in Th2 cytokine production by tissuelymphocytes in EoE
-
批准号:10307578
-
项目类别:
-
资助金额:$39.75万
-
财政年份:2019
-
负责人:Marc E. Rothenberg
-
依托单位:
Roles of FFAR 3-SCFA axis in Th2 cytokine production by tissuelymphocytes in EoE
-
批准号:10513830
-
项目类别:
-
资助金额:$39.75万
-
财政年份:2019
-
负责人:Marc E. Rothenberg
-
依托单位:
Role of Aiolos in eosinophilic asthma
-
批准号:10092082
-
项目类别:
-
资助金额:$39.0万
-
财政年份:2017
-
负责人:Marc E. Rothenberg
-
依托单位:
Genetic and Immunological Dissection of Eosinophilic Esophagitis
-
批准号:10364802
-
项目类别:
-
资助金额:$65.86万
-
财政年份:2015
-
负责人:Marc E. Rothenberg
-
依托单位:
Genetic and Immunological Dissection of Eosinophilic Esophagitis
-
批准号:9130755
-
项目类别:
-
资助金额:$55.5万
-
财政年份:2015
-
负责人:Marc E. Rothenberg
-
依托单位:
Genetic and Immunological Dissection of Eosinophilic Esophagitis
-
批准号:10539310
-
项目类别:
-
资助金额:$67.88万
-
财政年份:2015
-
负责人:Marc E. Rothenberg
-
依托单位:
Consortium of Eosinophilic Gastrointestinal Disease Researchers
-
批准号:8764284
-
项目类别:
-
资助金额:$125.0万
-
财政年份:2014
-
负责人:Marc E. Rothenberg
-
依托单位:
Admin Core
-
批准号:10242128
-
项目类别:
-
资助金额:$43.26万
-
财政年份:2014
-
负责人:Marc E. Rothenberg
-
依托单位:
Clinical Trial 2
-
批准号:10478132
-
项目类别:
-
资助金额:$34.57万
-
财政年份:2014
-
负责人:Marc E. Rothenberg
-
依托单位:
Clinical Trial 2
-
批准号:10684941
-
项目类别:
-
资助金额:$31.23万
-
财政年份:2014
-
负责人:Marc E. Rothenberg
-
依托单位:
Consortium of Eosinophilic Gastrointestinal Disease Researchers
-
批准号:9325420
-
项目类别:
-
资助金额:$145.0万
-
财政年份:2014
-
负责人:Marc E. Rothenberg
-
依托单位:
Consortium of Eosinophilic Gastrointestinal Disease Researchers
-
批准号:10019460
-
项目类别:
-
资助金额:$151.89万
-
财政年份:2014
-
负责人:Marc E. Rothenberg
-
依托单位:
Consortium of Eosinophilic Gastrointestinal Disease Researchers
-
批准号:10242127
-
项目类别:
-
资助金额:$145.97万
-
财政年份:2014
-
负责人:Marc E. Rothenberg
-
依托单位:
Consortium of Eosinophilic Gastrointestinal Disease Researchers
-
批准号:9115048
-
项目类别:
-
资助金额:$159.68万
-
财政年份:2014
-
负责人:Marc E. Rothenberg
-
依托单位:
Consortium of Eosinophilic Gastrointestinal Disease Researchers
-
批准号:9803035
-
项目类别:
-
资助金额:$177.07万
-
财政年份:2014
-
负责人:Marc E. Rothenberg
-
依托单位:
Consortium of Eosinophilic Gastrointestinal Disease Researchers
-
批准号:10478127
-
项目类别:
-
资助金额:$144.98万
-
财政年份:2014
-
负责人:Marc E. Rothenberg
-
依托单位:
Admin Core
-
批准号:10478128
-
项目类别:
-
资助金额:$35.79万
-
财政年份:2014
-
负责人:Marc E. Rothenberg
-
依托单位:
海外基金